|Print This Page Email to a Friend|
Brian K. West, RCS, RVS, a cardiovascular technologist and technical director with the University of South Alabama Medical Center’s Heart Station, was the first echosonographer on a nationwide clinical trial to officially complete certification training.
Working with USA’s Dr. Karen Fagan, West is part of a nationwide research study, “GS-4997 in Adults with Pulmonary Arterial Hypertension and Right Ventricular Dysfunction,” sponsored by Gilead Sciences. An associate professor of internal medicine, Dr. Fagan also is director of the Division of Pulmonary & Critical Care and the Pulmonary Hypertension Center.
The research study in question compares the efficacy, safety and tolerability of the drug called GS-4997 to a placebo in adults with the disease. As part of the approval process for becoming an official clinical trial site, West had to complete certification training.
The process included submitting one echocardiogram study performed in accordance with protocol to The Brigham & Women’s Hospital Cardiac Imaging Core Laboratory (CICL) in Boston for scrutinized review. The CICL provides independent analysis and adherence to pertinent protocols of cardiac imaging studies during a clinical research study. West was the first echosonographer associated with the study to complete this process.
“The purpose of the sonographer certification is to ensure consistency in how echocardiograms are performed study-wide and delivery of the highest quality echocardiograms in a manner that is focused on patient care and quantitative measurements,” said West.
West is a Level Three cardiovascular technologist with 10 years experience. He has been with USA Medical Center for the past two years. He is a registered cardiac sonographer and registered vascular specialist.
© 2018 USA Health